Maria Esposito

31PUBLICATIONS
146CO-AUTHORS
Field organic and low chemical input horticulturePharmaceutical delivery technologiesHuman biophysicsPharmacogenomicsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 17, 2026
Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.

|Jul 01, 2026
Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials.

|Jun 12, 2026
Efficacy of Bimekizumab on Palmoplantar Psoriasis: A 16-Week Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis).

|Apr 15, 2026
Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study.

|Apr 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).

Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

Pageof 6

Frequent Collaborators

11 joint publications

Maria Concetta Fargnoli

10 joint publications

Luca Stingeni

8 joint publications

Maddalena Napolitano

7 joint publications

Andrea Chiricozzi